In the realm of cancer treatment, immuno-oncology stands as a beacon of hope, leveraging the body's immune system to combat malignancies. Yet, understanding the intricate workings of immuno-oncology drug candidates remains a formidable challenge. Enter CD8 ImmunoPET – a novel imaging technique offering insights into drug mechanisms. In this article, we explore the potential of CD8 ImmunoPET to provide a better understanding of the mechanism of action (MoA) of immuno-oncology drug candidates, shedding light on its applications in clinical trials.
